Position in PGEN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$2,142,675
-$143,943 QoQ
Shares Held
553,663
+1.2% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lansing Street Advisors holds $2,142,675 across 1 Biotechnology name. PGEN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
This page
|
553,663 | $2,142,675 |
All Filings in PGEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,142,675 | 553,663 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,286,618 | 547,038 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,799,755 | 547,038 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||